BioCam

About BioCam

BioCam develops medical monitoring solutions that enhance patient comfort by facilitating real-time communication between patients and healthcare providers. The technology reduces anxiety during medical procedures by providing clear, actionable insights into patient status.

<problem> Traditional capsule endoscopy requires patients to visit medical facilities, potentially causing anxiety and discomfort. Existing methods may also lack real-time monitoring and immediate alerts for medical personnel in case of abnormalities. </problem> <solution> BioCam offers a patient-friendly, remote capsule endoscopy solution that enables real-time monitoring of the entire gastrointestinal tract. The system includes an ingestible endoscopic capsule, AI-powered telemedicine platform, and a mobile application. The capsule transmits images of the digestive system, while the AI software automatically detects and marks potential lesions, alerting medical staff to abnormalities in real-time. The mobile app provides patients with necessary information for exam preparation, enhancing convenience and reducing the need for in-person visits. </solution> <features> - Endoscopic capsule for imaging the digestive system. - AI-powered telemedicine platform for automatic detection of potential threats. - Real-time monitoring and alerting of medical personnel. - Mobile application providing patients with exam preparation information. - Non-invasive method for gastrointestinal observation. - Capsule dimensions: 11 mm wide and 23 mm long. </features> <target_audience> The primary target audience includes healthcare providers seeking remote diagnostic solutions and patients who require non-invasive gastrointestinal examinations. </target_audience>

What does BioCam do?

BioCam develops medical monitoring solutions that enhance patient comfort by facilitating real-time communication between patients and healthcare providers. The technology reduces anxiety during medical procedures by providing clear, actionable insights into patient status.

Where is BioCam located?

BioCam is based in Laç, Poland.

When was BioCam founded?

BioCam was founded in 2019.

How much funding has BioCam raised?

BioCam has raised 480700.

Location
Laç, Poland
Founded
2019
Funding
480700
Employees
30 employees
Major Investors
Level2 Ventures

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

BioCam

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

BioCam develops medical monitoring solutions that enhance patient comfort by facilitating real-time communication between patients and healthcare providers. The technology reduces anxiety during medical procedures by providing clear, actionable insights into patient status.

biocam.pl3K+
cb
Crunchbase
Founded 2019 – Laç, Poland

Funding

$

Estimated Funding

$300K+

Major Investors

Level2 Ventures

Team (30+)

No team information available.

Company Description

Problem

Traditional capsule endoscopy requires patients to visit medical facilities, potentially causing anxiety and discomfort. Existing methods may also lack real-time monitoring and immediate alerts for medical personnel in case of abnormalities.

Solution

BioCam offers a patient-friendly, remote capsule endoscopy solution that enables real-time monitoring of the entire gastrointestinal tract. The system includes an ingestible endoscopic capsule, AI-powered telemedicine platform, and a mobile application. The capsule transmits images of the digestive system, while the AI software automatically detects and marks potential lesions, alerting medical staff to abnormalities in real-time. The mobile app provides patients with necessary information for exam preparation, enhancing convenience and reducing the need for in-person visits.

Features

Endoscopic capsule for imaging the digestive system.

AI-powered telemedicine platform for automatic detection of potential threats.

Real-time monitoring and alerting of medical personnel.

Mobile application providing patients with exam preparation information.

Non-invasive method for gastrointestinal observation.

Capsule dimensions: 11 mm wide and 23 mm long.

Target Audience

The primary target audience includes healthcare providers seeking remote diagnostic solutions and patients who require non-invasive gastrointestinal examinations.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.